China now leads India 2:1 in clinical trials
This article was originally published in Scrip
China has overtaken India in terms of share of new clinical trials. A ratio of 1:1 China:India in number of new trials in 2008 has been transformed into a 2:1 ratio in 2011. While China has expanded its clinical trial bases in the past 5 years, unpredictable regulations in India and slow approval timelines appear to have significantly hurt India's sector.